Iqvia price target raised to $265 from $235 at Truist

Truist analyst Jailendra Singh raised the firm’s price target on Iqvia (IQV) to $265 from $235 and keeps a Buy rating on the shares after its Q3 results. The company saw high-single-digit sequential growth and 20% growth in RFP flow, and in the company’s view, these datapoints reflect a reduction in the level of uncertainty in the market environment and the macro political environment, the analyst tells investors in a research note. There is a market narrative out there suggesting that certain companies are exploring pricing options more aggressively, but Iqvia reports that its win rates have been strong, the firm added.